10 Foundayo is available in six doses ranging from 0.8 mg to 17.2 mg
NICE Technology Appraisal guidance (TA875 for semaglutide/Wegovy and TA664 for liraglutide/Saxenda) recommends these medications for weight management in adults with: A body mass index (BMI) of at least 35 kg/m and At least one weight-related comorbidity (such as type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, or non-alcoholic fatty liver disease) For liraglutide (Saxenda), NICE TA664 specifies additional criteria including prediabetes (HbA1c 42-47 mmol/mol or fasting plasma glucose 5.5-6.9 mmol/L) or high risk of cardiovascular disease
Metabolaid (Lemon Verbena + Hibiscus) This patented botanical blend raises GLP-1 by 30% in just 8 weeks, per clinical data
GLP-1 Drug Market Drivers Innovations in Drug Delivery Systems Advancements in drug delivery systems are poised to enhance the efficacy and patient compliance of GLP-1 therapies
Tachycardia, palpitations, and increased blood pressure
The thumbnail below links to a short educational video that walks through typical handling practices, such as storing the vial at appropriate temperatures, reconstituting with bacteriostatic water under a hood, and labeling aliquots with concentration and lot number